Dr Byrne is the Clinical Director of Cardiovascular services at King’s College Hospital. He completed his undergraduate medical training in Bristol and then continued general professional medical training in the South-East of England and London. A PhD in the academic department of Cardiology at King’s College Hospital was awarded in 2004; this examined the molecular mechanisms underlying left ventricular hypertrophy.
His training in interventional cardiology was undertaken at King’s College Hospital from 2004, and continued on Vancouver Island, Canada. He was appointed as a consultant in 2008. As well as percutaneous coronary intervention, his clinical interests also include transoesophageal echocardiography and cardiac CT. He has also been involved in the development of the structural programme at Kings College Hospital, with the use of novel percutaneous techniques to treat aortic (TAVI) and mitral valve disease. His research interests have included the molecular mechanisms which underlie the development of left ventricular hypertrophy, and the application of coronary physiology in an interventional setting. His research has also explored the differences and potential advantages of intervention performed form the radial artery.
Comments are closed